Plasma thrombin-cleaved osteopontin elevation after carotid artery stenting in symptomatic ischemic stroke patients

Hypertension Research

Volumn 35, Issue 2, 2012, Pages 207-212

  Kurata, Mie ^a   Okura, Takafumi ^a   Kumon, Yoshiaki ^a   Tagawa, Masahiko ^a   Watanabe, Hideaki ^a   Nakahara, Toshinori ^b   Miyazaki, Tatsuhiko ^a   Higaki, Jitsuo ^a   Nose, Masato ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MAZDA HOSPITAL   (Japan)

Author keywords

atherosclerosis; biomarker; stenting; stroke; thrombin cleaved osteopontin

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OSTEOPONTIN; THROMBIN;

AGED; ARTICLE; BLOOD ANALYSIS; BRAIN ISCHEMIA; CAROTID ANGIOPLASTY; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; STROKE PATIENT; THROMBUS;

AGED; BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBRAL ANGIOGRAPHY; DIFFUSION MAGNETIC RESONANCE IMAGING; ENDARTERECTOMY, CAROTID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OSTEOPONTIN; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; STENTS; STROKE; THROMBIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856711423     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.177     Document Type: Article

References (25)

1. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. The Lancet 2003; 362: 1211-1224. (Pubitemid 37255350)
2. Marta Scatena LL, Cecilia M. Giachelli Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
3. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994; 14: 1648-1656.
4. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994; 74: 214-224. (Pubitemid 24029153)
5. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995; 95: 713-724.
6. Weintraub AS, Giachelli CM, Krauss RS, Almeida M, Taubman MB. Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. Am J Pathol 1996; 149: 259-272. (Pubitemid 26230997)
7. Kurata M, Okura T, Watanabe S, Fukuoka T, Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006; 111: 319-324. (Pubitemid 44690190)
8. de Kleijn DPV, Moll FL, Hellings WE, Ozsarlak-Sozer G, de Bruin P, Doevendans PA, Vink A, Catanzariti LM, Schoneveld AH, Algra A, Daemen MJ, Biessen EA, de Jager W, Zhang H, de Vries J-P, Falk E, Lim SK, van der Spek PJ, Sze SK, Pasterkamp G. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010; 30: 612-619.
9. Smith LL, Cheung H-K, Ling LE, Chen J, Sheppard D, Pytela R, Giachelli CM. Osteopontin n-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem 1996; 271: 28485-28491. (Pubitemid 26374670)
10. Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C, Yamazaki H, Okazaki I, Seki N, Fujii T, Uede T. Essential role of the cryptic epitope slayglr within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003; 112: 181-188. (Pubitemid 38056354)
11. Roubin GS, Iyer S, Halkin A, Vitek J, Brennan C. Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 2006; 113: 2021-2030.
12. Hellings WE, Peeters W, Moll FL, Piers SRD, van Setten J, Van der Spek PJ, de Vries JPPM, Seldenrijk KA, De Bruin PC, Vink A, Velema E, de Kleijn DPV, Pasterkamp G. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010; 121: 1941-1950.
13. Sluimer JC, Kolodgie FD, Bijnens APJJ, Maxfield K, Pacheco E, Kutys B, Duimel H, Frederik PM, van Hinsbergh VWM, Virmani R, Daemen MJAP. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions: Relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009; 53: 1517-1527.
14. Anderson GB, Ashforth R, Steinke DE, Ferdinandy R, Findlay JM. Ct angiography for the detection and characterization of carotid artery bifurcation disease. Stroke 2000; 31: 2168-2174.
15. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death : A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275. (Pubitemid 30262927)
16. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse III JR. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. a case-control study. Circulation 1990; 82: 1230-1242.
17. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996; 23: 645-649. (Pubitemid 26131823)
18. Tanaka N, Momiyama Y, Ohmori R, Yonemura A, Ayaori M, Ogura M, Sawada S, Kusuhara M, Nakamura H, Ohsuzu F. Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006; 26: e129-e130. (Pubitemid 44305353)
19. Kurata M, Okura T, Irita J, Enomoto D, Nagao T, Jotoku M, Miyoshi K, Desilva VR, Higaki J. Angiotensin ii receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension. J Hum Hypertens 2010; 25: 334-339.
20. Harloff A, Simon J, Brendecke S, Assefa D, Helbing T, Frydrychowicz A, Weber J, Olschewski M, Strecker C, Hennig J, Weiller C, Markl M. Complex plaques in the proximal descending aorta: An underestimated embolic source of stroke * Supplementary data-video. Stroke 2010; 41: 1145-1150.
21. Imanishi T, Ikejima H, Tsujioka A, Kuroi A, Kobayashi K, Shiomi M, Muragaki Y, Mochizuki S, Goto M, Yoshida K, Akasaka T. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor and angiotensin ii receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone watanabe heritable hyperlipidemic rabbits. Hypertens Res 2008; 31: 1199-1208.
22. Mochizuki S, Dahl̈f Br, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, Ohta M, Yamada T, Ogawa K, Kanae K, Kawai M, Seki S, Okazaki F, Taniguchi M, Yoshida S, Tajima N. Valsartan in a japanese population with hypertension and other cardiovascular disease (jikei heart study): A randomised, open-label, blinded endpoint morbiditymortality study. The Lancet 2007; 369: 1431-1439. (Pubitemid 46635780)
23. Myles T, Leung LLK. Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites. J Biol Chem 2008; 283: 17789-17796.
24. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C. Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study. Stroke 2011; 42: 10-16.
25. Yamamoto N, Nakashima T, Torikai M, Naruse T, Morimoto J, Kon S, Sakai F, Uede T. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol 2007; 7: 1460-1470. (Pubitemid 47302883)